Oral intake of Kluyveromyces marxianus B0399 plus Lactobacillus rhamnosus CECT 30579 to mitigate symptoms in COVID-19 patients: A randomized open label clinical trial

por Navarro-López, Vicente, Hernández-Belmonte, Adriana, Pérez Soto, Maria Isabel, Ayo-González, Maikel, Losa-Rodríguez, Guillermo, Ros-Sánchez, Esther, Martínez-Gabarrón, Maravillas, Sánchez-Pellicer, Pedro, Aguera-Santos, Juan, Núñez-Delegido, Eva, Ruzafa-Costas, Beatriz, Picó-Monllor, José Antonio, Navarro-Moratalla, Laura
Publicado 2022